Eli Lilly and Co (LLY)

LLY (NYSE:Drugs) EQUITY
$73.81
pos +0.37
+0.50%
Today's Range: 73.20 - 73.99 | LLY Avg Daily Volume: 4,487,900
Last Update: 03/27/15 - 1:35 PM EDT
Volume: 1,806,473
YTD Performance: 6.45%
Open: $73.52
Previous Close: $73.44
52 Week Range: $57.17 - $77.46
Oustanding Shares: 1,111,103,942
Market Cap: 82,614,334,849
6-Month Chart
TheStreet Ratings Grade for LLY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 5 5 6
Moderate Buy 1 1 1 1
Hold 9 9 9 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.23 2.23 2.23 2.10
Latest Dividend: 0.50
Latest Dividend Yield: 2.69%
Dividend Ex-Date: 02/11/15
Price Earnings Ratio: 33.35
Price Earnings Comparisons:
LLY Sector Avg. S&P 500
33.35 33.40 27.33
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
4.33% 27.77% 82.37%
GROWTH 12 Mo 3 Yr CAGR
Revenue -15.10 -0.19 -0.07
Net Income -49.00 -0.45 -0.18
EPS -48.50 -0.43 -0.17
Earnings for LLY:
EBITDA 4.71B
Revenue 19.62B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $0.76 $0.78 $3.16 $3.60
Number of Analysts 6 6 13 10
High Estimate $0.79 $0.87 $3.22 $3.95
Low Estimate $0.72 $0.74 $3.10 $3.24
Prior Year $0.70 $0.68 $2.78 $3.16
Growth Rate (Year over Year) 8.33% 14.95% 13.61% 14.01%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Here are healthcare stocks of all shares and sizes with strong charts.
Its Alzheimer's treatment impressed, but dosing questions remain.
Lilly's stock blossoms, while Amgen is headed for a pullback.
Update
Feb 11, 2015 | 6:41 AM EST
Leerink Global Healthcare Conference (Day 1 of 2) - 02/11/15 - 02/12/15 New York, NY

Prep for Dividend D-Day Danger Real Money Pro($)

Should you be tempted by the energy names?
Bullish
Jan 15, 2015 | 7:08 AM EST
LLY was upgraded to Neutral, Goldman Sachs said. $70 price target. Company is improving margins and can deliver double-digit annual ear...
Bearish
Jan 09, 2015 | 7:08 AM EST
LLY was downgraded to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $74 price target. 
Bearish
Jan 08, 2015 | 8:01 AM EST
LLY was downgraded from Buy to Hold, Deutsche Bank said. $75 price target. Valuation call, as the stock gained 35% in 2014. 
Bullish
Jan 08, 2015 | 7:48 AM EST
LLY was upgraded to Buy, Jefferies said. $80 price target. Company has an attractive pipeline and can expand margins. 

Lilly Cuts Guidance Real Money Pro($)

Break in!

Columnist Conversations

Renaissance RE Holdings (RNR) shares are breaking below a key channel support area marked by the intersection ...
American Express is headed for a re test of the February spike low. After three straight gap lower opens...
I agree - how can you not question the valuation after the huge move in KRFT shares. My thinking is, barring a...
CME is attempting to hold a key near term support area following a mid week breakdown. Wednesday was the ...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.